PTPN 2 phosphatase deletion in T cells promotes anti‐tumour immunity and CAR T‐cell efficacy in solid tumours
Open Access
- 5 December 2019
- journal article
- research article
- Published by Springer Science and Business Media LLC in The EMBO Journal
- Vol. 39 (2), e103637
- https://doi.org/10.15252/embj.2019103637
Abstract
Although adoptive T‐cell therapy has shown remarkable clinical efficacy in haematological malignancies, its success in combating solid tumours has been limited. Here, we report that PTPN2 deletion in T cells enhances cancer immunosurveillance and the efficacy of adoptively transferred tumour‐specific T cells. T‐cell‐specific PTPN2 deficiency prevented tumours forming in aged mice heterozygous for the tumour suppressor p53. Adoptive transfer of PTPN2‐deficient CD8+ T cells markedly repressed tumour formation in mice bearing mammary tumours. Moreover, PTPN2 deletion in T cells expressing a chimeric antigen receptor (CAR) specific for the oncoprotein HER‐2 increased the activation of the Src family kinase LCK and cytokine‐induced STAT‐5 signalling, thereby enhancing both CAR T‐cell activation and homing to CXCL9/10‐expressing tumours to eradicate HER‐2+ mammary tumours in vivo. Our findings define PTPN2 as a target for bolstering T‐cell‐mediated anti‐tumour immunity and CAR T‐cell therapy against solid tumours.Keywords
Funding Information
- National Health and Medical Research Council (APP1132373, APP1136680, APP1103037)
- National Institutes of Health (RO1 CA207288)
- Cancer Council Victoria (1106477)
This publication has 84 references indexed in Scilit:
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid LeukemiaThe New England Journal of Medicine, 2013
- T cell protein tyrosine phosphatase attenuates T cell signaling to maintain tolerance in miceJCI Insight, 2011
- Elevated Hypothalamic TCPTP in Obesity Contributes to Cellular Leptin ResistanceCell Metabolism, 2011
- An autoimmune-associated variant in PTPN2 reveals an impairment of IL-2R signaling in CD4+ T cellsGenes & Immunity, 2010
- Tumor masses support naive T cell infiltration, activation, and differentiation into effectorsThe Journal of Experimental Medicine, 2010
- Interleukin-2 and Inflammation Induce Distinct Transcriptional Programs that Promote the Differentiation of Effector Cytolytic T CellsImmunity, 2010
- Acquisition of a Potent and Selective TC-PTP Inhibitor via a Stepwise Fluorophore-Tagged Combinatorial Synthesis and Screening StrategyJournal of the American Chemical Society, 2009
- Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7Proceedings of the National Academy of Sciences of the United States of America, 2007
- Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controlsNature, 2007
- Protein tyrosine phosphatase function: the substrate perspectiveBiochemical Journal, 2007